Northwest Biotherapeutics Cash from Financing (TTM) Analysis

Northwest Biotherapeutics Inc (NWBO)

0.4721 -0.01 (-1.67%) USD | OTCM | Apr 23, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2002. Upgrade now.

Date	Value
December 31, 2023	52.76M
September 30, 2023	49.69M
June 30, 2023	48.86M
March 31, 2023	50.63M
December 31, 2022	41.97M
September 30, 2022	54.29M
June 30, 2022	46.92M
March 31, 2022	41.29M
December 31, 2021	48.13M
September 30, 2021	40.28M
June 30, 2021	48.04M
March 31, 2021	56.43M
December 31, 2020	52.70M
September 30, 2020	42.01M
June 30, 2020	26.18M
March 31, 2020	13.04M
December 31, 2019	9.952M
September 30, 2019	-6.003M
June 30, 2019	-4.788M
March 31, 2019	5.048M
December 31, 2018	7.871M
September 30, 2018	32.99M
June 30, 2018	39.02M
March 31, 2018	33.00M
December 31, 2017	34.29M

Date	Value
September 30, 2017	37.48M
June 30, 2017	37.07M
March 31, 2017	37.11M
December 31, 2016	38.31M
September 30, 2016	62.19M
June 30, 2016	55.38M
March 31, 2016	94.68M
December 31, 2015	93.95M
September 30, 2015	94.56M
June 30, 2015	116.27M
March 31, 2015	90.04M
December 31, 2014	85.82M
September 30, 2014	69.53M
June 30, 2014	60.30M
March 31, 2014	53.14M
December 31, 2013	48.95M
September 30, 2013	38.75M
June 30, 2013	31.22M
March 31, 2013	26.65M
December 31, 2012	30.15M
September 30, 2012	17.57M
June 30, 2012	11.76M
March 31, 2012	15.78M
December 31, 2011	14.62M
September 30, 2011	11.70M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-6.003M

Minimum

Sep 2019

56.43M

Maximum

Mar 2021

37.49M

Average

46.92M

Median

Jun 2022

Cash from Financing (TTM) Benchmarks